BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37028393)

  • 1. We con-dense if we want to; We can't leave AZUL outside.
    Dao TP; Castañeda CA
    Structure; 2023 Apr; 31(4):369-371. PubMed ID: 37028393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E6AP AZUL interaction with UBQLN1/2 in cells, condensates, and an AlphaFold-NMR integrated structure.
    Buel GR; Chen X; Myint W; Kayode O; Folimonova V; Cruz A; Skorupka KA; Matsuo H; Walters KJ
    Structure; 2023 Apr; 31(4):395-410.e6. PubMed ID: 36827983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angelman syndrome-associated point mutations in the Zn
    Kühnle S; Martínez-Noël G; Leclere F; Hayes SD; Harper JW; Howley PM
    J Biol Chem; 2018 Nov; 293(47):18387-18399. PubMed ID: 30257870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zn-binding AZUL domain of human ubiquitin protein ligase Ube3A.
    Lemak A; Yee A; Bezsonova I; Dhe-Paganon S; Arrowsmith CH
    J Biomol NMR; 2011 Sep; 51(1-2):185-90. PubMed ID: 21947926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of ubiquitin recognition by the ubiquitin-associated (UBA) domain of the ubiquitin ligase EDD.
    Kozlov G; Nguyen L; Lin T; De Crescenzo G; Park M; Gehring K
    J Biol Chem; 2007 Dec; 282(49):35787-95. PubMed ID: 17897937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The active form of E6-associated protein (E6AP)/UBE3A ubiquitin ligase is an oligomer.
    Ronchi VP; Klein JM; Edwards DJ; Haas AL
    J Biol Chem; 2014 Jan; 289(2):1033-48. PubMed ID: 24273172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The specificity of ubiquitin binding to ubiquilin-1 is regulated by sequences besides its UBA domain.
    Harman CA; Monteiro MJ
    Biochim Biophys Acta Gen Subj; 2019 Oct; 1863(10):1568-1574. PubMed ID: 31175912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.
    Drews CM; Brimer N; Vande Pol SB
    PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of the UBA domain of X-linked inhibitor of apoptosis protein reveals different surfaces for ubiquitin-binding and self-association.
    Tse MK; Hui SK; Yang Y; Yin ST; Hu HY; Zou B; Wong BC; Sze KH
    PLoS One; 2011; 6(12):e28511. PubMed ID: 22194841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The STI and UBA Domains of UBQLN1 Are Critical Determinants of Substrate Interaction and Proteostasis.
    Kurlawala Z; Shah PP; Shah C; Beverly LJ
    J Cell Biochem; 2017 Aug; 118(8):2261-2270. PubMed ID: 28075048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein.
    Liu X; Yuan H; Fu B; Disbrow GL; Apolinario T; Tomaic V; Kelley ML; Baker CC; Huibregtse J; Schlegel R
    J Biol Chem; 2005 Mar; 280(11):10807-16. PubMed ID: 15655249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitin-associated domain of cellular inhibitor of apoptosis proteins facilitates ubiquitylation.
    Budhidarmo R; Day CL
    J Biol Chem; 2014 Sep; 289(37):25721-36. PubMed ID: 25065467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A non-canonical UBA-UBL interaction forms the linear-ubiquitin-chain assembly complex.
    Yagi H; Ishimoto K; Hiromoto T; Fujita H; Mizushima T; Uekusa Y; Yagi-Utsumi M; Kurimoto E; Noda M; Uchiyama S; Tokunaga F; Iwai K; Kato K
    EMBO Rep; 2012 May; 13(5):462-8. PubMed ID: 22430200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of the transfer of ubiquitin from UbcH7 to E6AP.
    Purbeck C; Eletr ZM; Kuhlman B
    Biochemistry; 2010 Feb; 49(7):1361-3. PubMed ID: 20039703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Angelman syndrome substitution in the HECT E3 ubiquitin ligase C-terminal Lobe of E6AP affects protein stability and activity.
    Beasley SA; Kellum CE; Orlomoski RJ; Idrizi F; Spratt DE
    PLoS One; 2020; 15(7):e0235925. PubMed ID: 32639967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the catalytic C-lobe of the HECT-type ubiquitin ligase E6AP.
    Ries LK; Liess AKL; Feiler CG; Spratt DE; Lowe ED; Lorenz S
    Protein Sci; 2020 Jun; 29(6):1550-1554. PubMed ID: 31994269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Previously uncharacterized interactions between the folded and intrinsically disordered domains impart asymmetric effects on UBQLN2 phase separation.
    Zheng T; Galagedera SKK; Castañeda CA
    Protein Sci; 2021 Jul; 30(7):1467-1481. PubMed ID: 34029402
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Buel GR; Chen X; Kayode O; Cruz A; Walters KJ
    Biomol NMR Assign; 2023 Jun; 17(1):101-106. PubMed ID: 37022617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational flexibility underlies ubiquitin ligation mediated by the WWP1 HECT domain E3 ligase.
    Verdecia MA; Joazeiro CA; Wells NJ; Ferrer JL; Bowman ME; Hunter T; Noel JP
    Mol Cell; 2003 Jan; 11(1):249-59. PubMed ID: 12535537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein.
    Cooper EM; Hudson AW; Amos J; Wagstaff J; Howley PM
    J Biol Chem; 2004 Sep; 279(39):41208-17. PubMed ID: 15263005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.